首页> 美国卫生研究院文献>Oncology Reports >Downregulation of S100A4 expression by RNA interference suppresses cell growth and invasion in human colorectal cancer cells
【2h】

Downregulation of S100A4 expression by RNA interference suppresses cell growth and invasion in human colorectal cancer cells

机译:RNA干扰下调S100A4表达可抑制人结肠直肠癌细胞的生长和侵袭

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

S100A4 protein, a member of the S100 superfamily of calcium-binding proteins, is frequently observed in various types of human cancers, including colorectal cancer (CRC). Our previous investigations have demonstrated that the overexpression of S100A4 is associated with lymph node metastasis and poor prognosis in CRC; however, its biological roles in CRC remain unclear. In the present study, we compared the expression of S100A4 at the mRNA and protein levels in six CRC cell lines, and found that the expression levels roughly coincided with their invasiveness. Using RNA interference, we suppressed S100A4 expression in SW620 CRC cells with highly invasive potential and S100A4 high expression. The specific knockdown of S100A4 strongly suppressed cell growth, migration and invasion activities. Furthermore, employing metastasis-related gene mRNA microarrays, we found four genes to be significantly dysregulated (more than 2-fold) after downregulation of S100A4, including three downregulated genes (MMP9, MMP10 and CDH11) and one upregulated gene (TIMP4). Our present results indicate that S100A4 may positively regulate tumor cell proliferation, invasion and metastasis associated with multiple molecules. Thus, the inhibition of S100A4 might be a potentially novel approach to treatment for CRC.
机译:S100A4蛋白是钙结合蛋白S100超家族的成员,经常在各种类型的人类癌症中发现,包括结直肠癌(CRC)。我们以前的研究表明,S100A4的过表达与CRC的淋巴结转移和预后不良有关。然而,其在CRC中的生物学作用仍不清楚。在本研究中,我们比较了六个CRC细胞系中S100A4在mRNA和蛋白水平上的表达,发现该表达水平与它们的侵袭性大致吻合。使用RNA干扰,我们抑制了S620A4在SW620 CRC细胞中的表达,并具有高度侵袭性和S100A4的高表达。 S100A4的特定敲低强烈抑制细胞生长,迁移和入侵活动。此外,利用与转移相关的基因mRNA微阵列,我们发现S100A4下调后四个基因显着失调(超过2倍),包括三个下调基因(MMP9,MMP10和CDH11)和一个上调基因(TIMP4)。我们目前的结果表明,S100A4可能正调控与多个分子相关的肿瘤细胞的增殖,侵袭和转移。因此,抑制S100A4可能是治疗CRC的潜在新方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号